Cargando…

Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling

Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell-based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multi-potency, hMSCs render the tissue microenvironment more favorable for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hyo-Jin, Park, Jihye, Shin, Joo-Hyun, Chang, Mi-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716453/
https://www.ncbi.nlm.nih.gov/pubmed/29039467
http://dx.doi.org/10.3892/ijmm.2017.3173
_version_ 1783283957699182592
author Jeon, Hyo-Jin
Park, Jihye
Shin, Joo-Hyun
Chang, Mi-Sook
author_facet Jeon, Hyo-Jin
Park, Jihye
Shin, Joo-Hyun
Chang, Mi-Sook
author_sort Jeon, Hyo-Jin
collection PubMed
description Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell-based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multi-potency, hMSCs render the tissue microenvironment more favorable for tissue repair by secreting various growth factors. Our previous study demonstrated that hMSCs secrete several growth factors, including several insulin-like growth factor binding proteins (IGFBPs). Among these, IGFBP-6 binds with high affinity and inhibits insulin growth factor-2 (IGF-2) to inhibit the growth of IGF-2-dependent tumors. However, the function of IGFBP-6 in the nervous system remains to be fully elucidated. The present study investigated the protective effects of IGFBP-6 secreted by hMSCs on H(2)O(2)-injured primary cortical neuron cultures and lysolecithin-injured organotypic spinal cord slice cultures. Treatment of the H(2)O(2)-injured cortical neurons with conditioned media from hMSCs (hMSC-CM) increased the phosphorylation of Akt, reduced cell death and mitochondrial translocation of Bax, and regulated extracellular levels of IGF-1 and IGF-2. MTT assay, western blot analysis and ELISA were used to detect the cell viability and protein expression levels, respectively. An inhibitory antibody against IGFBP-6 eliminated this hMSC-CM-mediated neuroprotective effect in the injured cortical neuron cultures and spinal cord slice cultures. In addition, treatment with cyclolignan picropodophyllin, an inhibitor of IGF-1 receptor (IGF-1R), significantly inhibited neuronal protection by hMSC-CM. These findings demonstrated that hMSC-CM-mediated neuroprotection was attributed to IGF-1R-mediated signaling, potentiated via the inhibition of IGF-2 by IGFBP-6. The results of the present study provide insight into the mechanism by which hMSC administration may promote recovery from nerve injury.
format Online
Article
Text
id pubmed-5716453
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57164532017-12-10 Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling Jeon, Hyo-Jin Park, Jihye Shin, Joo-Hyun Chang, Mi-Sook Int J Mol Med Articles Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell-based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multi-potency, hMSCs render the tissue microenvironment more favorable for tissue repair by secreting various growth factors. Our previous study demonstrated that hMSCs secrete several growth factors, including several insulin-like growth factor binding proteins (IGFBPs). Among these, IGFBP-6 binds with high affinity and inhibits insulin growth factor-2 (IGF-2) to inhibit the growth of IGF-2-dependent tumors. However, the function of IGFBP-6 in the nervous system remains to be fully elucidated. The present study investigated the protective effects of IGFBP-6 secreted by hMSCs on H(2)O(2)-injured primary cortical neuron cultures and lysolecithin-injured organotypic spinal cord slice cultures. Treatment of the H(2)O(2)-injured cortical neurons with conditioned media from hMSCs (hMSC-CM) increased the phosphorylation of Akt, reduced cell death and mitochondrial translocation of Bax, and regulated extracellular levels of IGF-1 and IGF-2. MTT assay, western blot analysis and ELISA were used to detect the cell viability and protein expression levels, respectively. An inhibitory antibody against IGFBP-6 eliminated this hMSC-CM-mediated neuroprotective effect in the injured cortical neuron cultures and spinal cord slice cultures. In addition, treatment with cyclolignan picropodophyllin, an inhibitor of IGF-1 receptor (IGF-1R), significantly inhibited neuronal protection by hMSC-CM. These findings demonstrated that hMSC-CM-mediated neuroprotection was attributed to IGF-1R-mediated signaling, potentiated via the inhibition of IGF-2 by IGFBP-6. The results of the present study provide insight into the mechanism by which hMSC administration may promote recovery from nerve injury. D.A. Spandidos 2017-12 2017-10-05 /pmc/articles/PMC5716453/ /pubmed/29039467 http://dx.doi.org/10.3892/ijmm.2017.3173 Text en Copyright: © Jeon et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Jeon, Hyo-Jin
Park, Jihye
Shin, Joo-Hyun
Chang, Mi-Sook
Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title_full Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title_fullStr Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title_full_unstemmed Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title_short Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling
title_sort insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through igf-1r-mediated signaling
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716453/
https://www.ncbi.nlm.nih.gov/pubmed/29039467
http://dx.doi.org/10.3892/ijmm.2017.3173
work_keys_str_mv AT jeonhyojin insulinlikegrowthfactorbindingprotein6releasedfromhumanmesenchymalstemcellsconfersneuronalprotectionthroughigf1rmediatedsignaling
AT parkjihye insulinlikegrowthfactorbindingprotein6releasedfromhumanmesenchymalstemcellsconfersneuronalprotectionthroughigf1rmediatedsignaling
AT shinjoohyun insulinlikegrowthfactorbindingprotein6releasedfromhumanmesenchymalstemcellsconfersneuronalprotectionthroughigf1rmediatedsignaling
AT changmisook insulinlikegrowthfactorbindingprotein6releasedfromhumanmesenchymalstemcellsconfersneuronalprotectionthroughigf1rmediatedsignaling